Literature DB >> 12136060

Evidence for a genetic association between monoamine oxidase A and restless legs syndrome.

A Desautels1, G Turecki, J Montplaisir, K Brisebois, A Sequeira, B Adam, G A Rouleau.   

Abstract

BACKGROUND: Impairment in the central dopaminergic system has been consistently suggested as an etiologic factor in restless legs syndrome (RLS).
OBJECTIVE: To investigate a possible role for the MAOA and MAOB genes in RLS using a population-based association study.
METHODS: In addition to a dinucleotide repeat located within the second intron of the MAOB gene, a functional variable number of tandem repeat (VNTR) polymorphism recently identified in the MAOA gene promoter region was examined, using 96 extensively characterized patients and 200 control subjects matched for ethnic background. The relationship between variation at these loci and several clinical features was also considered.
RESULTS: Pertaining to the MAOA gene, females with the high activity allele had a greater risk (OR: 2.0; 95% CI: 1.06 to 3.77) of being affected with RLS than females carrying the low activity alleles. The authors did not observe this association among the male subjects (OR: 0.98; 95% CI: 0.31 to 3.14). Interestingly, females carrying the high transcription alleles showed a longer sleep onset latency (U = 163.5; p = 0.015) and exhibited a higher movement index during the Suggested Immobilization Test (Student's t-test = -2.02; p = 0.048). No differences were observed regarding the MAOB gene in our sample.
CONCLUSIONS: The high activity allele of the MAOA gene may represent a modifying factor involved in the severity of RLS manifestations in females.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12136060     DOI: 10.1212/wnl.59.2.215

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  Recent advances in the diagnosis, genetics and treatment of restless legs syndrome.

Authors:  Claudia Trenkwalder; Birgit Högl; Juliane Winkelmann
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

Review 2.  An update on the pathophysiology and genetics of restless legs syndrome.

Authors:  Lynn Marie Trotti; Srinivas Bhadriraju; David B Rye
Journal:  Curr Neurol Neurosci Rep       Date:  2008-07       Impact factor: 5.081

3.  Restless legs syndrome: pathophysiology and treatment.

Authors:  William G Ondo
Journal:  Curr Treat Options Neurol       Date:  2014-11       Impact factor: 3.598

Review 4.  Genetic aspects of restless legs syndrome.

Authors:  V Dhawan; M Ali; K R Chaudhuri
Journal:  Postgrad Med J       Date:  2006-10       Impact factor: 2.401

Review 5.  Restless legs syndrome.

Authors:  William G Ondo
Journal:  Curr Neurol Neurosci Rep       Date:  2005-07       Impact factor: 5.081

6.  Sleep disturbance as detected by actigraphy in pre-pubertal juvenile monkeys receiving therapeutic doses of fluoxetine.

Authors:  Mari S Golub; Casey E Hogrefe
Journal:  Neurotoxicol Teratol       Date:  2016-03-05       Impact factor: 3.763

7.  Genotyping sleep disorders patients.

Authors:  Daniel F Kripke; Farhad F Shadan; Arthur Dawson; John W Cronin; Shazia M Jamil; Alexandra P Grizas; James A Koziol; Lawrence E Kline
Journal:  Psychiatry Investig       Date:  2010-02-22       Impact factor: 2.505

Review 8.  Genetics of restless legs syndrome.

Authors:  Juliane Winkelmann
Journal:  Curr Neurol Neurosci Rep       Date:  2008-05       Impact factor: 5.081

Review 9.  Whole genome association studies in complex diseases: where do we stand?

Authors:  Anna C Need; David B Goldstein
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

10.  Association between Antipsychotics-Induced Restless Legs Syndrome and Tyrosine Hydroxylase Gene Polymorphism.

Authors:  Chul-Hyun Cho; Seung-Gul Kang; Jung-Eun Choi; Young-Min Park; Heon-Jeong Lee; Leen Kim
Journal:  Psychiatry Investig       Date:  2009-07-15       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.